By Reuters Staff
2 Min Read
TOKYO, May 31 (Reuters) - Japanese shares closed lower on Monday, as investors locked in gains after a recent rally, although the losses were limited by a positive finish from local drugmakers.
The Nikkei share average ended 0.99% lower at 28,860.08, while the broader Topix fell 1.26% to 1,922.98.
The Nikkei had jumped 2.1% on Friday to close at the 29,000-level for the first time since May 10, while Wall Street finished with marginal gains.
“There aren’t any reasons to buy Japanese stocks at the moment except that the vaccine rollouts are proceeding well. That is helping cap the declines in the session,” said Yutaka Miura, senior technical analyst at Mizuho Securities.
By Reuters Staff
June 3 (Reuters) - U.S. CDC: U.S. CDC SAYS DELIVERED 368,375,195 DOSES OF COVID-19 VACCINE AS OF JUNE 3 VERSUS 366,977,535 DOSES DELIVERED AS OF JUNE 2 U.S. CDC SAYS ADMINISTERED 297,720,928 DOSES OF COVID-19 VACCINE AS OF JUNE 3 VERSUS 296,912,892 DOSES ADMINISTERED AS OF JUNE 2 U.S. CDC SAYS 169,090,262 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 3 VERSUS 168,734,435 INDIVIDUALS AS OF JUNE 2 U.S. CDC SAYS 136,644,618 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 3 VERSUS 136,155,250 INDIVIDUALS AS OF JUNE 2
Major Japanese companies are set to open COVID-19 vaccination centres this month, as the country races to speed up inoculations before the start of the Tokyo Olympics in July.
Wealthy countries need to give more COVID-19 vaccines and follow the United States in making doses available immediately to cover a 200 million dose gap caused by Indian supply disruptions and manufacturing delays, a WHO senior adviser said on Friday.